MedPath

ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues

Not Applicable
Completed
Conditions
Infiltration of Peripheral IV Therapy
Interventions
Device: ivWatch Model 400 with SmartTouch and fiber optic sensor
Registration Number
NCT04065373
Lead Sponsor
ivWatch, LLC
Brief Summary

A single arm study of 40 adult volunteers to assess the safety and efficacy of the ivWatch SmartTouch and fiber optic sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Informed consent
  • Pass health screen
  • 18 years or older
Exclusion Criteria
  • Fail health screen

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Non-Infiltrated TissueivWatch Model 400 with SmartTouch and fiber optic sensorThe ivWatch Model 400 with SmartTouch or fiber optic sensor monitored a common peripheral IV site over a 24 hour observation period.
Primary Outcome Measures
NameTimeMethod
Normal Tissue Red Notification Rate24 Hours

The ivWatch Model 400 issues red notifications to communicate the need for a clinician to check an IV site. A red notification suggests an increased likelihood that an IV infiltration may be occurring, with a greater likelihood relative to a yellow notification. This measure describes the average number of red notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the red notification rate was calculated using a negative binomial regression model.

Secondary Outcome Measures
NameTimeMethod
Normal Tissue Yellow Notification Rate24 Hours

The ivWatch Model 400 issues yellow notifications to communicate the need for a clinician to check an IV site. A yellow notification suggests an increased likelihood that an IV infiltration may be occurring, although at a lower likelihood relative to a red notification. This measure describes the average number of yellow notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the yellow notification rate was calculated using a negative binomial regression model.

Significant Skin Irritation or Disruption to Skin Integrity24 Hours

The number of IV sites with significant skin irritation or disruption to skin integrity assessed at the end of the study. The Clopper-Pearson method was used for estimating the binomial proportion confidence interval.

Trial Locations

Locations (1)

ivWatch, LLC

🇺🇸

Williamsburg, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath